An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
NCT00002089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the efficacy and safety of azithromycin given chronically for the treatment of Mycobacterium avium (MAC) bacteremia in patients failing or intolerant of current available MAC therapy.
Conditions
- Mycobacterium Avium-Intracellulare Infection
- HIV Infections
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
NCT00002122 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
NCT00002331 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
NCT00001030 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
NCT00002139 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
NCT00001058 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00001039 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
NCT00002192 ·Status: COMPLETED ·Phase: PHASE2
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
NCT00002080 ·Status: COMPLETED ·Phase: NA
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002032 ·Status: COMPLETED ·Phase: NA
-
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
NCT00002082 ·Status: COMPLETED ·Phase: NA
-
A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients
NCT00000907 ·Status: COMPLETED
-
A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
NCT00000895 ·Status: COMPLETED ·Phase: NA
-
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00001995 ·Status: COMPLETED ·Phase: NA
-
Azithromycin/Bicillin Syphilis
NCT00031499 ·Status: COMPLETED ·Phase: PHASE3
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002267 ·Status: COMPLETED ·Phase: NA
-
A Study of Azithromycin in HIV-Infected Patients
NCT00002344 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS
NCT00000644 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
NCT00001047 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients
NCT01227395 ·Status: COMPLETED
-
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
NCT00000966 ·Status: COMPLETED ·Phase: PHASE1
-
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
NCT00002101 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
NCT00000860 ·Status: COMPLETED
-
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
NCT00000641 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
NCT00002170 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
NCT00000971 ·Status: COMPLETED ·Phase: PHASE1